The stabilizer MTR-106 is a close analog of CX-5461 that shows specific toxicity against BRCA-deficient tumors resistant to PARP inhibition [25]; its high binding strength towards PARP1 G4 supports its significant antiproliferative activity in HR-deficient and PARPi-resistant cancer cells [27]. The gene discussed is PARP1; the disease is cancer.